1. EMEA Guideline on risk management systems for medicinal products for human use (CHMP) (2005) Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/2010/WC500004888.pdf . Accessed Feb 2011
2. Volume 9A of The Rules Governing Medicinal Products in the European Union (2006) Guidelines on Pharmacovigilance for Medicinal Products for Human Use (2008). Available at: http://ec.europa.eu/health/files/pharmacos/docs/doc2005/2012-2005/draft_of_volume_2009a_2012_2005_en.pdf . Accessed Feb 2011
3. Lettre aux prescripteurs adressée par les laboratoires Crinex (2006) Information importante de pharmacovigilance Uvestérol Vitamine ADEC, solution buvable Uvestérol D 1500UI/mL, solution buvable. Available at: http://www.afssaps.fr/content/download/11927/142830/version/142832/file/ddl_uvesterol.pdf . Accessed Feb 2011
4. Communiqué de presse de l'AFSSAPS (2006) Nouvelles recommandations d'administration pour Uvestérol vitaminé ADEC et Uvestérol D 1500UI/mL. http://www.afssaps.fr/Infos-de-securite/Communiques-de-presse/Nouvelles-recommandations-d-administration-pour-Uvesterol-Vitamine-ADEC-et-Uvesterol-D-1500UI-mL . Accessed Feb 2011
5. Mol PG, Straus SM, Piening S, de Vries JT, de Graeff PA, Haaijer-Ruskamp FM (2010) A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009. Drug Saf 33:463–474 4. doi: 10.2165/11532840-000000000-00000